Most Popular Stories
- Hospitals lose reimbursement for 'unnecessary' ER visits
- Healthcare jobs will grow the fastest of all industries
- Online tools, social media ease clinical recruiting, research
- Hospital exec arrested in $116M Medicare scheme
- Medicaid cuts loom despite overdue reimbursements
- Docs not always honest with patients
Featured Jobs
-
Epic Ambulatory Beacon Consultant
Meditology Services - NC -
Electronic Health Records Application Support Manager RN-New Year New Career
Avanti on behalf of Respected Health System - San Francisco, CA -
ICD-10 Revenue Cycle, Manager
Meditology Services - Atlanta, GA
Events
- ICD-10 Reality Check - Breakfast Panel at HiMSS 2012!
February 22, 2012 - From IHI: The Patient Experience Seminar
March 27-28 — Boston, MA - Medical Devices Summit 2012
March 6-7 2012 — The Boston Park Plaza Hotel & Towers, Boston, MA - IHI's Transforming the Primary Care Practice
May 1-3, 2012 — San Diego, CA
Paid Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
Merck to pay $9M in Vioxx trial
A jury in Atlantic City, NJ, said Merck must pay $9 million in punitive damages to a man who says he suffered a heart attack after taking Vioxx, surprising observers who expected the drug giant to escape the latest episode of its legal saga relatively unscathed. Last week, the same jury awarded 77-year-old John McDarby $4.5 million in compensatory damages. The award surprised some legal analysts. Under New Jersey's tort reform law, punitive damages in pharmaceutical cases are not allowed unless the plaintiff shows that the party involved intentionally misled regulators about the safety of a drug or product. Merck shares fell to $34.20 in morning trading.
- see this article from The Wall Street Journal
Related Stories
- MA anesthesiologist accused of fabricating 21 studies
- Justice Department recovers $1.12 billion from fraud
- FL sues Merck over Vioxx marketing
- Merck agrees to $58M settlement on Vioxx ads
- Studies show problems with four big-name drugs
- Reports suggest that Merck downplayed Vioxx risks
- ALSO NOTED: TN Medicaid to test e-prescribing program; NIH alerts patients of stolen personal information; and much more...
- Merck agrees to pay$650M+ to settle suits
- Despite safety issues, Vioxx still in demand
- SPOTLIGHT: Hung jury forces mistrial in Vioxx suit
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| Editors | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |
